O, B., MS, F., S, A., E, M., K, B., G, K., . . . S, S. (2026). Treatment Attrition From Surgery to Adjuvant Therapy in Stage IIB and IIIA Lung Adenocarcinoma: A National Cancer Database Analysis. Clinical lung cancer, 27(5), 106. https://doi.org/10.1016/j.cllc.2026.04.013
Chicago Style (17th ed.) CitationO, Bushara, Farooq MS, Ahn S, Marostica E, Bruestle K, Karakousis G, Kucharczuk JC, and Singhal S. "Treatment Attrition From Surgery to Adjuvant Therapy in Stage IIB and IIIA Lung Adenocarcinoma: A National Cancer Database Analysis." Clinical Lung Cancer 27, no. 5 (2026): 106. https://doi.org/10.1016/j.cllc.2026.04.013.
MLA (9th ed.) CitationO, Bushara, et al. "Treatment Attrition From Surgery to Adjuvant Therapy in Stage IIB and IIIA Lung Adenocarcinoma: A National Cancer Database Analysis." Clinical Lung Cancer, vol. 27, no. 5, 2026, p. 106, https://doi.org/10.1016/j.cllc.2026.04.013.